Masud, Sanna N.
Chandrashekhar, Megha
Aregger, Michael http://orcid.org/0000-0001-6443-9870
Tan, Guihong http://orcid.org/0000-0001-7334-1154
Zhang, Xiaoyu
Mero, Patricia
Pirman, David A.
Zaslaver, Olga
Smolen, Gromoslaw A. http://orcid.org/0000-0003-0136-4685
Lin, Zhen-Yuan
Wong, Cassandra J.
Boone, Charles http://orcid.org/0000-0002-3542-6760
Gingras, Anne-Claude http://orcid.org/0000-0002-6090-4437
Montenegro-Burke, J. Rafael http://orcid.org/0000-0001-7787-3414
Moffat, Jason http://orcid.org/0000-0002-5663-8586
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (PGC463531)
Ontario Ministry of Research, Innovation and Science (RE9)
Article History
Received: 7 May 2019
Accepted: 7 July 2022
First Online: 15 August 2022
Change Date: 24 August 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41589-022-01146-9
Competing interests
: J.M. is an advisor and shareholder of Century Therapeutics and Aelian Biotechnology.